Emotional and Clinical Aspects Observed in Women with Gestational Trophoblastic Disease: A Multidisciplinary Action

Overview

Journal Rev Bras Ginecol Obstet

Specialty Gynecology & Obstetrics

Date 2022 Feb 9

PMID 35139569

Authors

Ana Carolina Gomes Franca

Elza Maria Hartmann Uberti

Karine Paiva Muller

Rodrigo Bernardes Cardoso

Fabiana Giguer

Patricia El Beitune

Antonio Braga

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the emotional and clinical aspects observed in women with gestational trophoblastic disease (GTD) followed-up in a reference center (RC) by a multidisciplinary team.

Methods: Retrospective cohort study of the clinical records of 186 women with GTD and of the emotional aspects (EA) observed in these women by a team of psychologists and reported by the 389 support groups conducted from 2014 to 2018.

Results: The women were young (mean age: 31.2 years), 47% had no living child, 60% had planned the pregnancy, and 50% participated in two or more SG. Most women (n = 137; 73.6%) reached spontaneous remission of molar gestation in a median time of 10 weeks and had a total follow-up time of seven months. In the group of 49 women (26.3%) who progressed to gestational trophoblastic neoplasia (GTN), time to remission after chemotherapy was 18 weeks, and total follow-up time was 36 months. EA included different levels of anxiety and depression, more evident in 9.1% of the women; these symptoms tended to occur more frequently in women older than 40 years ( = 0.067), less educated ( = 0.054), and whose disease progressed to GTN ( = 0.018), as well as in those who had to undergo multi-agent chemotherapy ( = 0.028) or hysterectomy ( = 0.001) adjuvant to clinical treatment.

Conclusion: This study found several EA in association with all types of GTD. It also highlights the importance of specialized care only found in a RC, essential to support the recovery of the mental health of these women.

Citing Articles

Association of gestational trophoblastic disease with subsequent development of non-trophoblastic cancer.

Munyakarama B, Koushik A, Leduc V, Healy-Profitos J, Auger N Int J Gynaecol Obstet. 2024; 168(3):1305-1311.

PMID: 39425609 PMC: 11823342. DOI: 10.1002/ijgo.15976.

Expert Pathology for Gestational Trophoblastic Disease: Towards an International Multidisciplinary Team Meeting.

Kaur B, Nadal A, Bartosch C, Rougemont A Gynecol Obstet Invest. 2024; 89(3):166-177.

PMID: 38190817 PMC: 11151979. DOI: 10.1159/000536028.

References

Braga A, Mora P, de Melo A, Nogueira-Rodrigues A, Amim-Junior J, Rezende-Filho J . Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide. World J Clin Oncol. 2019; 10(2):28-37. PMC: 6390119. DOI: 10.5306/wjco.v10.i2.28. View

Freitas F, Braga A, Viggiano M, Velarde L, Maesta I, Uberti E . Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. Gynecol Oncol. 2020; 158(2):452-459. DOI: 10.1016/j.ygyno.2020.04.704. View

Petersen R, Ung K, Holland C, Quinlivan J . The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life. Gynecol Oncol. 2005; 97(2):535-42. DOI: 10.1016/j.ygyno.2005.01.015. View

Braga A, Torres B, Burla M, Maesta I, Sun S, Lin L . Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?. Gynecol Oncol. 2016; 143(3):558-564. DOI: 10.1016/j.ygyno.2016.09.012. View

Jorm A, Korten A, Jacomb P, Christensen H, Rodgers B, Pollitt P . "Mental health literacy": a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Med J Aust. 1997; 166(4):182-6. DOI: 10.5694/j.1326-5377.1997.tb140071.x. View

Li L, Wan X, Feng F, Ren T, Yang J, Zhao J . Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia. BMC Cancer. 2018; 18(1):585. PMC: 5966914. DOI: 10.1186/s12885-018-4512-5. View

Katz M, Jacobson T, Veledar E, Kripalani S . Patient literacy and question-asking behavior during the medical encounter: a mixed-methods analysis. J Gen Intern Med. 2007; 22(6):782-6. PMC: 2583801. DOI: 10.1007/s11606-007-0184-6. View

Ngan H, Tang G . Psychosocial aspects of gestational trophoblastic disease in Chinese residents of Hong Kong. J Reprod Med. 1986; 31(3):173-8. View

Uberti E, Diestel M, Guimaraes F, Goloubkova T, Rosa M, de Napoli G . Gestational trophoblastic disease: one more risk in adolescent pregnancy. Acta Obstet Gynecol Scand. 2002; 81(4):356-63. DOI: 10.1034/j.1600-0412.2002.810415.x. View

10.

Ngan H, Bender H, Benedet J, Jones H, Montruccoli G, Pecorelli S . Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet. 2004; 83 Suppl 1:175-7. DOI: 10.1016/s0020-7292(03)90120-2. View

11.

Sun S, Goldstein D, Bernstein M, Horowitz N, Mattar R, Maesta I . Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013. J Reprod Med. 2016; 61(5-6):210-4. View

12.

Pires L, Uberti E, Fajardo M, da Cunha A, Rosa M, Ayub A . Role of hysterectomy in the management of patients with gestational trophoblastic neoplasia: importance of receiving treatment in reference centers. J Reprod Med. 2012; 57(7-8):359-68. View

13.

Stafford L, Judd F . What do women with gestational trophoblastic disease understand about the condition?. Int J Gynecol Cancer. 2010; 21(1):161-6. DOI: 10.1097/IGC.0b013e31820156d8. View

14.

Ferreira E, Maesta I, Michelin O, de Paula R, Consonni M, Rudge M . Assessment of quality of life and psychologic aspects in patients with gestational trophoblastic disease. J Reprod Med. 2009; 54(4):239-44. View

15.

Di Mattei V, Mazzetti M, Carnelli L, Bernardi M, Di Pierro R, Bergamini A . [Gestational Trophoblastic Disease: psychological impact and the role of defence mechanisms during illness and follow-up]. Recenti Prog Med. 2016; 106(12):641-5. DOI: 10.1701/2094.22658. View

16.

Gillett S, Singh K, Ireson J, Hills A, Winter M, Tidy J . Evolution of a Teenage and Young Adult Service, in Sheffield, U.K., for Patients with Gestational Trophoblastic Neoplasia. J Reprod Med. 2016; 61(5-6):235-7. View

17.

Ngan H, Seckl M, Berkowitz R, Xiang Y, Golfier F, Sekharan P . Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018; 143 Suppl 2:79-85. DOI: 10.1002/ijgo.12615. View

18.

Garner E, Goldstein D, Berkowitz R, Wenzel L . Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003; 17(6):959-68. DOI: 10.1016/s1521-6934(03)00093-2. View

19.

Braga A, Maesta I, Michelin O, Delmanto L, Consonni M, Rudge M . Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women. Gynecol Oncol. 2008; 112(3):568-71. DOI: 10.1016/j.ygyno.2008.10.027. View

20.

Quinlivan J, Ung K, Petersen R . The impact of molar pregnancy on the male partner. Psychooncology. 2011; 21(9):970-6. DOI: 10.1002/pon.1992. View